Klaus H. Jensen
- Co-authors
- Toshinari AsakuraJohn B. BuseXavier Pi‐SunyerBernard ZinmanKevin D. NiswenderDavid Russell‐JonesAnders ToftGiorgio Sesti
- Topics
- Diabetes Treatment and Management (8 papers)Diabetes Management and Research (7 papers)Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers)
- Journals
- PLoS ONEDiabetesOncotarget
- Partner nations
- DenmarkUnited StatesUnited Kingdom
In The Last Decade
Klaus H. Jensen
12 papers receiving 274 citations
Peers
Comparison fields: 5 of 51
- Endocrinology, Diabetes and Metabolism 244
- Molecular Biology 85
- Surgery 69
- Pharmacology 52
- Genetics 25
Countries citing papers authored by Klaus H. Jensen
This map shows the geographic impact of Klaus H. Jensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus H. Jensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus H. Jensen more than expected).
Fields of papers citing papers by Klaus H. Jensen
This network shows the impact of papers produced by Klaus H. Jensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus H. Jensen. The network helps show where Klaus H. Jensen may publish in the future.
Co-authorship network of co-authors of Klaus H. Jensen
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus H. Jensen. A scholar is included among the top collaborators of Klaus H. Jensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus H. Jensen. Klaus H. Jensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 8 | |
| 4 | 13 | |
| 5 | 86 | |
| 6 | 45 | |
| 7 | Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c) | 1 |
| 8 | 19 | |
| 9 | 29 | |
| 10 | 22 | |
| 11 | 17 | |
| 12 | 43 |
About Klaus H. Jensen
Klaus H. Jensen is a scholar working on Endocrinology, Diabetes and Metabolism, Family Practice and Oncology, having authored 12 papers that have together received 290 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Diabetes Management and Research (7 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (244 citations), Family Practice (17 citations) and Pharmacology (52 citations). Klaus H. Jensen has collaborated with scholars based in Denmark, United States and United Kingdom. Frequent co-authors include Toshinari Asakura, John B. Buse, Xavier Pi‐Sunyer, Bernard Zinman, Kevin D. Niswender, David Russell‐Jones, Anders Toft, Giorgio Sesti, Hiroaki Seino and Melanie J. Davies. Their work appears in journals such as PLoS ONE, Diabetes and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.